🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This trial is divided into two parts, a dose-escalation study (phase 1) and...
Status
Suspended
Location
University of Alabama at Birmingham
Start Date
2013-08
Trial ID
NCT01933815
Treatments Being Tested
This is a multicenter, randomized, double-blind, placebo-controlled, dose-E...
Status
Completed
Location
Allife Medicine （Beijing） Limitied
Start Date
2023-08-24
Trial ID
NCT05993884
The purpose of this study is: * To assess the effect of BIA 5 1058 400 mg ...
Status
Completed
Location
Simbec Research Ltd (Simbec)
Start Date
2018-06-11
Trial ID
NCT07173738
Treatments Being Tested
To evaluate the safety and tolerability of single dose of SYH2082 Injection...
Status
Active Not Recruiting
Location
The Affiliated Hospital of Nanjing University Medical School
Start Date
2026-04-13
Trial ID
NCT07736404
Treatments Being Tested
This study is a randomized, double-blind and placebo-controlled trial with ...
Status
Completed
Location
Peking University People's Hospital
Start Date
2015-05
Trial ID
NCT02460393
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability, single-a...
Status
Completed
Location
Parexel International
Start Date
2024-07-11
Trial ID
NCT06562114
Treatments Being Tested
The purpose of this study is to generate safety, reactogenicity (assessment...
Status
Completed
Location
GSK Investigational Site
Start Date
2019-08-05
Trial ID
NCT04026009
Multicenter, prospective, open-labeled, 2-arm, non-comparative randomized p...
Status
Completed
Location
Institut Bergonié
Start Date
2022-02-09
Trial ID
NCT04807816
Treatments Being Tested
The goal of this clinical trial is to learn about ISM5411 in healthy subjec...
Status
Completed
Location
Nucleus Network
Start Date
2023-11-08
Trial ID
NCT06012578
This clinical trial is evaluating tucatinib in combination with Doxil in pa...
Status
Recruiting
Location
Maryland Oncology Hematology
Start Date
2023-07-24
Trial ID
NCT05748834